Aberrant mTORC1 activation kills tubular cells by inactivating miR148b-3p

Ken Inoki1

  • 1Life Sciences Institute, University of Michigan, Ann Arbor, Michigan, USA; Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan, USA; Division of Nephrology, Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.

Kidney International
|November 26, 2016
PubMed

Insights

Aberrant activation of mechanistic target of rapamycin complex 1 in kidney cells causes injury and death by increasing endoplasmic reticulum stress in diabetes. This pathway involves reduced miR-148b-3p, leading to tumor necrosis factor signaling and worsening kidney dysfunction.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Diabetology

Background:

  • Diabetic kidney disease is a major complication of diabetes.
  • The precise molecular mechanisms underlying renal tubular cell injury in diabetes require further elucidation.

Purpose of the Study:

  • To investigate the role of mechanistic target of rapamycin complex 1 (mTORC1) in diabetic renal tubular cell injury.
  • To identify the molecular pathways linking mTORC1 activation to cell death and dysfunction under diabetic conditions.

Main Methods:

  • The study utilized a combination of in vitro and in vivo models to examine renal tubular cells under diabetic conditions.
  • Molecular techniques were employed to assess mTORC1 activation, endoplasmic reticulum stress, apoptosis, and microRNA expression.

Main Results:

  • Aberrant activation of mTORC1 in renal tubular cells was found to exacerbate endoplasmic reticulum stress and promote cell death.
  • mTORC1 activation was shown to suppress miR-148b-3p expression, leading to enhanced tumor necrosis factor (TNF) signaling.
  • This molecular cascade resulted in significant renal tubular cell dysfunction.

Conclusions:

  • mTORC1 plays a critical role in mediating renal tubular cell injury and death in diabetes.
  • The identified pathway involving mTORC1, miR-148b-3p, and TNF signaling represents a novel mechanism contributing to diabetic kidney disease progression.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K